Observational studyJournal of bone and mineral metabolism2022

Risk factors for poor response to denosumab treatment in Japanese postmenopausal women with osteoporosis.

Tokutaro Okawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.